Camarillo, CA, United States of America

Shing S Kwan

This inventor holds 1 USPTO granted patent. Top assignee: Medical Analysis Systems, Inc.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shing S Kwan: Innovator in Alpha-Amylase Reagents

Introduction

Shing S Kwan is a notable inventor based in Camarillo, California. He has made significant contributions to the field of biochemistry, particularly in the development of reagents for enzyme assays. His innovative work has led to the creation of a stable single liquid alpha-amylase reagent, which has practical applications in medical analysis.

Latest Patents

Shing S Kwan holds a patent for a stable single liquid alpha-amylase reagent. This reagent comprises a polysaccharide or long chain oligosaccharide substrate for alpha-amylase, featuring an optically detectable label bonded to the reducing end glucose. The reagent also includes beta-amylase and either alpha- or beta-glucosidase, with sorbitol added to retard enzyme degradation. The preparation process involves filtering the enzymes and substrate through a 0.2 micron or less filter to ensure purity.

Career Highlights

Kwan is associated with Medical Analysis Systems, Inc., where he applies his expertise in enzyme assays. His work has been instrumental in advancing the capabilities of medical diagnostics through innovative reagent development.

Collaborations

Shing S Kwan has collaborated with notable colleagues such as Ivan E Modrovich and Leon C Wortham, contributing to the advancement of their shared goals in medical analysis.

Conclusion

Shing S Kwan's contributions to the field of biochemistry, particularly through his patented alpha-amylase reagent, highlight his role as an innovator in medical diagnostics. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…